C V Starr & Co. Inc.
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 11, 2026), C V Starr & Co. Inc. reported 5 stock positions worth $191.8 million. Its top holding was SPDR Gold Shares (GLD) at 56.4% of the portfolio, followed by iShares Core MSCI Dev MKTS (IDEV, 16.5%) and Vanguard S&P Mid-Cap 400 ETF (IVOO, 13.6%). Its holdings were unchanged from Q4 2025.
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001340459
- Portfolio Value
- $191.8M (Q1 2026)
- SEC Filing
- 0001140361-26-020617 ↗ filed May 11, 2026
Holdings Value
Holdings 5 stocks · $191.8M
| GLD SPDR Gold Shares | 56.41% | 251,400 | $108.2M | No change |
| IDEV iShares Core MSCI Dev MKTS | 16.51% | 378,787 | $31.7M | No change |
| IVOO Vanguard S&P Mid-Cap 400 ETF | 13.56% | 227,427 | $26.0M | No change |
| IJR iShares Core S&P Small-Cap E | 12.99% | 200,458 | $24.9M | No change |
| CELU Celularity Inc. Class A | 0.53% | 764,069 | $1.0M | No change |
Portfolio Sells Q4 2025 → Q1 2026
| None this quarter. | |||
Portfolio Buys Q4 2025 → Q1 2026
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $187.3M | GLD, IDEV, IJR, IVOO, CELU |
| Q1 2026 | 5 | $191.8M | GLD, IDEV, IVOO, IJR, CELU |
| Q4 2025 | 5 | $182.0M | GLD, IDEV, IVOO, IJR, CELU |
| Q3 2025 | 5 | $216.6M | GLD, IDEV, IVOO, IJR, CELU |
| Q2 2025 | 5 | $192.4M | GLD, IDEV, IVOO, IJR, CELU |
| Q1 2025 | 5 | $129.8M | GLD, IEFA, MDY, VB, CELU |
| Q4 2024 | 6 | $128.1M | GLD, IEFA, VO, IJR, AMZN |